HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Khalili Selected Research

K Khalili Research Topics

Disease

15Neoplasms (Cancer)
01/2008 - 05/2000
7Glioblastoma (Glioblastoma Multiforme)
03/2002 - 08/2000
6Infections
08/2006 - 10/2000
5Medulloblastoma
04/2007 - 08/2000
5Acquired Immunodeficiency Syndrome (AIDS)
09/2003 - 05/2000
4Retinoblastoma (Glioblastoma, Retinal)
08/2006 - 05/2000
4Carcinogenesis
08/2006 - 10/2000
4Brain Neoplasms (Brain Tumor)
10/2001 - 05/2000
3Progressive Multifocal Leukoencephalopathy
12/2011 - 06/2000
2Multiple Sclerosis
12/2011 - 03/2007
2Disease Progression
09/2003 - 02/2001
2Glioma (Gliomas)
05/2001 - 08/2000
2Virus Diseases (Viral Diseases)
02/2001 - 05/2000
1Rheumatoid Arthritis
12/2011
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
12/2011
1Psoriasis (Pustulosis Palmaris et Plantaris)
12/2011
1Neuroblastoma
08/2008
1Chromosome Aberrations (Chromosome Abnormalities)
01/2008
1Hypersensitivity (Allergy)
04/2007
1Cerebellar Neoplasms
04/2007
1Nervous System Diseases (Neurological Disorders)
12/2001
1AIDS Dementia Complex
12/2001
1Lymphoma (Lymphomas)
10/2001
1Astrocytoma (Pilocytic Astrocytoma)
05/2001
1HIV Infections (HIV Infection)
02/2001
1Pituitary Neoplasms (Pituitary Adenoma)
10/2000
1Demyelinating Diseases (Demyelinating Disease)
05/2000
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
05/2000

Drug/Important Bio-Agent (IBA)

16Proteins (Proteins, Gene)FDA Link
08/2006 - 05/2000
14Tumor Viral Antigens (Large T Antigen)IBA
04/2007 - 05/2000
5Oncogene Proteins (Oncogene Protein)IBA
04/2007 - 05/2000
3DNA (Deoxyribonucleic Acid)IBA
08/2006 - 05/2001
3AntibodiesIBA
10/2001 - 02/2001
3NF-kappa B (NF-kB)IBA
05/2001 - 08/2000
2Natalizumab (Tysabri)FDA Link
12/2011 - 03/2007
2Viral ProteinsIBA
09/2004 - 08/2001
2CytokinesIBA
09/2003 - 02/2001
2Capsid Proteins (Capsid Protein)IBA
03/2002 - 06/2000
2AntigensIBA
12/2001 - 08/2000
2Transcription Factors (Transcription Factor)IBA
05/2001 - 12/2000
1efalizumab (Raptiva)FDA Link
12/2011
1Rituximab (Mabthera)FDA Link
12/2011
1Monoclonal AntibodiesIBA
12/2011
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
08/2008
1Therapeutic UsesIBA
01/2008
1Antineoplastic Agents (Antineoplastics)IBA
01/2008
1Cisplatin (Platino)FDA LinkGeneric
01/2008
1SuspensionsIBA
04/2007
1NVP-AEW541IBA
04/2007
1Insulin-Like Growth Factor I (IGF-1)IBA
04/2007
1IGF Type 1 Receptor (IGF 1 Receptor)IBA
04/2007
1Glycogen Synthase Kinase 3 betaIBA
04/2007
1Interferon beta-1aFDA Link
03/2007
1Interleukin-4 (Interleukin 4)IBA
09/2003
1Interleukin-2 (IL2)IBA
09/2003
1Interleukin-13IBA
09/2003
1Interleukin-10 (Interleukin 10)IBA
09/2003
1Interleukin-6 (Interleukin 6)IBA
09/2003
1Viral DNAIBA
03/2002
1Lipopolysaccharide ReceptorsIBA
12/2001
1Biomarkers (Surrogate Marker)IBA
12/2001
1Flurbiprofen (Froben)FDA LinkGeneric
10/2001
1Ribonucleases (Ribonuclease)IBA
10/2001
1Cell Cycle ProteinsIBA
10/2001
1beta CateninIBA
08/2001
1Lymphoid Enhancer-Binding Factor 1IBA
08/2001
1Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
05/2001
1TubulinIBA
05/2001
1Messenger RNA (mRNA)IBA
05/2001
1Antiviral Agents (Antivirals)IBA
02/2001
1AutoantibodiesIBA
02/2001
1VaccinesIBA
02/2001
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2001
1Tumor Suppressor Protein p53IBA
10/2000
1IntegrinsIBA
08/2000
1Tetracycline (Achromycin)FDA LinkGeneric
05/2000

Therapy/Procedure

2Therapeutics
12/2011 - 03/2007
2Drug Therapy (Chemotherapy)
03/2001 - 05/2000
1Transplantation
08/2000